The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical evaluation of germline polymorphisms (SNPs) associated with disease response to capecitabine in metastatic breast cancer (MBC) (TBCRC 015).
 
Noura Choudhury
No Relationships to Disclose
 
Patrick Evans
No Relationships to Disclose
 
James N. Ingle
No Relationships to Disclose
 
Ingrid A. Mayer
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis
Research Funding - Novartis; Pfizer
 
Phuong Khanh H. Morrow
Employment - Amgen
Leadership - Amgen
Stock and Other Ownership Interests - Amgen
 
Anna Maria Storniolo
Employment - Boston Pharmaceuticals (I)
Leadership - Boston Pharmaceuticals (I)
Stock and Other Ownership Interests - Amgen; Amgen (I)
Consulting or Advisory Role - Lilly
 
Andres Forero-Torres
Speakers' Bureau - Seagen
Research Funding - Daiichi Sankyo (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Novartis (Inst); Oncothyreon (Inst); Pfizer (Inst); Seagen (Inst); Syndax (Inst); TRACON Pharma (Inst)
 
Catherine H. Van Poznak
Research Funding - Bayer (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Douglas E. Merkel
No Relationships to Disclose
 
Elizabeth Claire Dees
Consulting or Advisory Role - Novartis (I)
Research Funding - Bayer; Cerulean Pharma; Genentech/Roche; Lilly; Merck; Novartis; Pfizer
 
Gini F. Fleming
Research Funding - Corcept Therapeutics (Inst)
 
Olwen Mary Hahn
Honoraria - Cardinal Health (I)
Consulting or Advisory Role - Pfizer; Pfizer
Travel, Accommodations, Expenses - Cardinal Health (I)
 
Philip C. Hoffman
No Relationships to Disclose
 
Olufunmilayo I. Olopade
Employment - CancerIQ (I)
Leadership - CancerIQ
Stock and Other Ownership Interests - CancerIQ; Tempus
Research Funding - Novartis (Inst)
Other Relationship - Bio Ventures for Global Health; Color Genomics; Myriad Genetics; Roche/Genentech; Tempus
 
Nancy Cox
No Relationships to Disclose
 
Rita Nanda
Consulting or Advisory Role - AstraZeneca; Celgene; Genentech/Roche; Merck; Pfizer; Puma Biotechnology; Syndax
Research Funding - Celgene; Corcept Therapeutics; Merck
Other Relationship - G1 Therapeutics
 
Peter H. O'Donnell
Stock and Other Ownership Interests - Allergan
Honoraria - Algeta ASA; American Medical Forum; Astellas Pharma; AstraZeneca; Genentech/Roche; Harrison Consulting Group; Inovio Pharmaceuticals; Janssen Biotech; Kantar Health; Merck; Novartis; Parexel; Quintiles; Seagen; Xcenda
Research Funding - Acerta Pharma (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Genentech/Roche (Inst); Janssen (Inst); Merck (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Named as co-inventor on a pending patent for a genomic prescribing system for medication prescribing.
Expert Testimony - TERA; Triage Cancer
Travel, Accommodations, Expenses - Merck
Other Relationship - Advance Medical